false
OasisLMS
zh-CN,zh-TW,en,fr,de,hi,ja,ko,pt,es
Login
Catalog
Islet Cell Therapy: Emerging Strategy to Treat Typ ...
Islet Cell Therapies Webinar
Islet Cell Therapies Webinar
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. Anna Lam reviews autoimmune type 1 diabetes and islet transplantation. Despite advances in glucose-monitoring systems and insulin pumps, many patients still experience severe hypoglycemia, distress, and the burden of daily management.<br /><br />Type 1 diabetes progresses through stages: autoantibodies can identify early disease before glucose abnormalities, while multiple autoantibodies indicate a high lifetime risk. Early detection enables education, monitoring, reduced risk of diabetic ketoacidosis at diagnosis, and potential use of disease-modifying therapy.<br /><br />Deceased-donor islet transplantation is an established option for selected patients, particularly those with problematic hypoglycemia or unstable glucose control. Islets are infused into the liver, but recipients need lifelong immunosuppression. Many achieve insulin independence, often after multiple transplants, though it commonly lasts only a few years. More durable benefits include improved glucose stability and protection from severe hypoglycemia. Key risks include infection, cancer, and declining kidney function.<br /><br />Emerging approaches aim to overcome limited donor supply and immunosuppression risks. These include stem-cell-derived islets, personalized cell therapies, gene-edited “hypoimmune” cells, and alternative immunosuppressive regimens. Early results are promising, but further studies are needed. Lam emphasizes careful patient selection and coordinated, multidisciplinary care.
Meta Tag
Concept
Type 1 Diabetes Mellitus
Concept
Islet Transplantation
Concept
Beta Cell Replacement
Concept
Autoimmune Disease
Concept
Diabetes Autoantibody
Keywords
type 1 diabetes
autoimmune diabetes
islet transplantation
autoantibodies
severe hypoglycemia
insulin independence
stem-cell-derived islets
immunosuppression
hypoimmune cells
Autoantibody screening
Disease-modifying therapy
×
Please select your language
1
English